191. Werner syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 3 / Drugs : 4 - (DrugBank : 3) / Drug target gene : 0 - Drug target pathway : 0
Drugs and their primary sponsors and trial info
Growth hormone
National Center for Research Resources (NCRR)
1992 - NCT00004815 -
Nicotinamide riboside
Yokote Koutaro
2021 Phase 1-2 JPRN-jRCTs031190141 Japan;
Progerinin
PRG Science & Technology Co., Ltd.
2020 Phase 1 NCT04512963 United States;
National Center for Research Resources (NCRR)
1992 - NCT00004815 -
Nicotinamide riboside
Yokote Koutaro
2021 Phase 1-2 JPRN-jRCTs031190141 Japan;
Progerinin
PRG Science & Technology Co., Ltd.
2020 Phase 1 NCT04512963 United States;